Active ingredient
- mesalazine
Legal Category
POM: Prescription only medicine
POM: Prescription only medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 36633/0011.
Octasa 1g Suppositories
Package leaflet: information for the user
Octasa 1g Suppositories
Mesalazine
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
What is in this leaflet:
1. What Octasa 1g Suppositories are and what they are used for
2. What you need to know before you use Octasa 1g Suppositories
3. How to use Octasa 1g Suppositories
4. Possible side effects
5. How to store Octasa 1g Suppositories
6. Contents of the pack and other information
1. What Octasa 1g Suppositories are and what they are used for
Octasa 1g Suppositories contain the active substance mesalazine (also known as 5-aminosalicylic acid) which is an anti-inflammatory drug used in the treatment of Ulcerative proctitis – a disease of the back passage (rectum) in which the lining of the bowel becomes inflamed (red and swollen). Symptoms can include rectal bleeding, frequent diarrhoea and abdominal pain.
The suppositories act locally in the rectum to reduce inflammation and can also prevent further episodes (flares) of ulcerative proctitis.
2. What you need to know before you use Octasa 1g Suppositories
Do not use Octasa 1g Suppositories
Warnings and precautions
Talk to your doctor before using Octasa 1g Suppositories
Further precautions
During treatment your doctor may want to keep you under close medical supervision, and you may need to have regular blood and urine tests.
Kidney stones may develop with use of mesalazine. Symptoms may include pain in sides of abdomen and blood in urine. Take care to drink sufficient amount of liquid during treatment with mesalazine.
Serious skin reactions including Stevens-Johnson syndrome, toxic epidermal necrolysis have been reported in association with mesalazine treatment. Stop using mesalazine and seek medical attention immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.
Other medicines and Octasa 1g Suppositories
Tell your doctor, if you take or use any of the medicines mentioned below, as the effects of these medicines may change (interactions):
Tell your doctor or pharmacist, if you are taking, have recently taken or might take any other medicines. It may still be all right for you to use Octasa 1g Suppositories and your doctor will be able to decide, what is suitable for you.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
You should only use Octasa 1g Suppositories during pregnancy, if your doctor tells you to.
You should also only use Octasa 1g Suppositories during breast-feeding, if your doctor tells you to, as this medicine may pass into breast milk.
Driving and using machines
Octasa 1g Suppositories are not expected to affect your ability to drive or operate machines.
Important information about some of the ingredients of Octasa 1g Suppositories
The other ingredient in Octasa 1g Suppositories is not likely to cause side effects (see section 6. Contents of the pack and other information).
3. How to use Octasa 1g Suppositories
Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist, if you are not sure.
Method of administration
This medicine may only be used rectally, so it has to be inserted through the anus. Do NOT take by mouth.
Dosage
Adults and older people
To treat acute phase of ulcerative proctitis your recommended dose is one Octasa 1g Suppository once a day, at bedtime.
To prevent ulcerative proctitis your recommended dose is one Octasa 1g Suppository once a day, at bedtime.
The dose should be adjusted by your doctor as per your condition.
Use in children
There is little experience and only limited documentation for an effect in children.
Duration of treatment
Your doctor will decide how long you need to continue the treatment with this medicine. This will depend on your condition.
To obtain the maximum benefit from this medicine, you should use Octasa 1g Suppositories regularly and consistently, as directed.
If you think your Octasa 1g Suppositories are too strong or too weak, talk to your doctor.
If you use more Octasa 1g Suppositories than you should
Contact a doctor if you are in doubt, so he or she can decide what to do.
If you use too much Octasa 1g Suppositories on one occasion, just take your next dose as prescribed.
Do not use a smaller amount.
If you forget to use Octasa 1g Suppositories
If you forget to use this medicine, use it as soon as you remember. However, if it is almost time for your next dose, skip the dose you missed. Then use the next dose at its usual time. Do not use a double dose to make up for a forgotten dose.
If you stop using Octasa 1g Suppositories
Do not stop using this product until you have talked to your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
All medicines can cause allergic reactions although serious allergic reactions are very rare. If you get any of the following symptoms after using this medicine, you should contact your doctor immediately:
If you experience a marked reduction of your general health, especially if accompanied by fever, and/or a sore throat and mouth, stop using these suppositories and contact your doctor immediately.
These symptoms can, very rarely, be due to a fall in the number of white cells in your blood (a condition called agranulocytosis), which may make you more prone to developing a serious infection. A blood test can confirm whether your symptoms are due to an effect of this medicine on your blood.
The following side effects have also been reported by patients using mesalazine:
Rare side effects (may affect up to 1 in 1,000 patients):
Very rare side effects (may affect up to 1 in 10,000 patients):
Not known (frequency cannot be estimated from the available data)
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme online at yellowcard.mhra.gov.uk or via the free Yellow Card app.
By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Octasa 1g Suppositories
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister strip and on the carton.
The expiry date refers to the last day of that month.
Do not store above 30°C. Do not refrigerate or freeze.
Store in the original container in order to protect contents from light.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
6. Contents of the pack and other information
What Octasa 1g Suppositories contain
The active substance in Octasa 1g Suppositories is mesalazine, and one suppository of Octasa 1g Suppositories contains 1g mesalazine.
The other ingredient is
hard fat.
What Octasa 1g Suppositories look like and contents of the pack
Octasa 1g Suppositories are light beige coloured, torpedo-shaped suppositories.
Octasa 1g Suppositories are available in packs of 10, 30 suppositories.
Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
The marketing authorisation holder is:
The manufacturer is:
To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge:
0800 198 5000 (UK only)
Please be ready to give the following information:
Product name Octasa 1g Suppositories
Reference number PL 36633/0011
This leaflet was last revised in December 2020.
Wellingore Hall, Wellingore, Lincolnshire, LN5 0HX,, UK
+44 (0)1522 813500